Shannon N. Westin, MD, MPH, FACOG, discusses the rationale for the use of combination immunotherapy for advanced and recurrent endometrial cancer.
Shannon N. Westin, MD, MPH, The University of Texas MD Anderson Cancer Center
Advertisement
Articles by Shannon N. Westin, MD, MPH, The University of Texas MD Anderson Cancer Center
Advertisement
Latest Updated Articles
Role of Combination I/O in Advanced Endometrial Cancer (EC)April 14th 2021
Advertisement
Advertisement
Trending on OncLive
1
CHMP Recommends Approval of Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer
2
SurVaxM Cancer Vaccine Shows Clinically Meaningful OS Signal in Newly Diagnosed Glioblastoma
3
VS-7375 Elicits Responses in KRAS G12D–Mutated Pancreatic Cancer
4
FDA Approves Nogapendekin Alfa Inbakicept Plus BCG for High-Grade, Papillary-Only BCG-Unresponsive NMIBC
5